Freeman-Cook; Kevin Daniel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Freeman-Cook; Kevin Daniel.The latest application filed is for "sulfonyl amide derivatives for the treatment of abnormal cell growth".
- Freeman-Cook; Kevin Daniel - Clinton CT
- Freeman-Cook; Kevin Daniel - Carlsbad CA
- Freeman-Cook; Kevin Daniel - San Diego CA
- Freeman-Cook, Kevin Daniel - US
| Patent | Date |
|---|---|
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20220251066 - Luzzio; Michael Joseph ; et al. | 2022-08-11 |
| CDK2/4/6 inhibitors Grant 11,396,512 - Behenna , et al. July 26, 2 | 2022-07-26 |
| Anti-proliferative agents for treating PAH Grant 11,203,594 - Bhattacharya , et al. December 21, 2 | 2021-12-21 |
| Cdk2 Inhibitors App 20210269425 - Behenna; Douglas Carl ; et al. | 2021-09-02 |
| Cdk2 Inhibitors App 20210261530 - Behenna; Douglas Carl ; et al. | 2021-08-26 |
| CDK2 inhibitors Grant 11,014,911 - Behenna , et al. May 25, 2 | 2021-05-25 |
| CDK2/4/6 Inhibitors App 20200392142 - Behenna; Douglas Carl ; et al. | 2020-12-17 |
| Anti-proliferative Agents For Treating Pah App 20200331909 - Bhattacharya; Samit Kumar ; et al. | 2020-10-22 |
| CDK2/4/6 inhibitors Grant 10,800,783 - Behenna , et al. October 13, 2 | 2020-10-13 |
| Cdk2 Inhibitors App 20200247784 - Kind Code | 2020-08-06 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20200002310 - Luzzio; Michael Joseph ; et al. | 2020-01-02 |
| CDK2/4/6 Inhibitors App 20190135817 - Behenna; Douglas Carl ; et al. | 2019-05-09 |
| CDK2/4/6 inhibitors Grant 10,233,188 - Freeman-Cook , et al. | 2019-03-19 |
| CDK2/4/6 Inhibitors App 20180044344 - Behenna; Douglas Carl ; et al. | 2018-02-15 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20170001981 - Luzzio; Michael Joseph ; et al. | 2017-01-05 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20160130250 - Luzzio; Michael Joseph ; et al. | 2016-05-12 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20150080368 - Luzzio; Michael Joseph ; et al. | 2015-03-19 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20140100368 - Luzzio; Michael Joseph ; et al. | 2014-04-10 |
| Sulfonyl amide derivatives for the treatment of abnormal cell growth Grant 8,440,822 - Luzzio , et al. May 14, 2 | 2013-05-14 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20130005964 - Luzzio; Michael Joseph ; et al. | 2013-01-03 |
| Sulfonyl amide derivatives for the treatment of abnormal cell growth Grant 8,247,411 - Luzzio , et al. August 21, 2 | 2012-08-21 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20110166120 - Luzzio; Michael Joseph ; et al. | 2011-07-07 |
| Sulfonyl amide derivatives for the treatment of abnormal cell growth Grant 7,928,109 - Luzzio , et al. April 19, 2 | 2011-04-19 |
| Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors App 20110009443 - Freeman-Cook; Kevin Daniel ; et al. | 2011-01-13 |
| Sulfonyl Amide Derivatives For The Treatment Of Abnormal Cell Growth App 20090054395 - Luzzio; Michael Joseph ; et al. | 2009-02-26 |
| Amine Derivatives Useful As Anticancer Agents App 20080051419 - Corbett; Matthew Stephen ; et al. | 2008-02-28 |
| Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors Grant 7,119,201 - Reiter , et al. October 10, 2 | 2006-10-10 |
| Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors App 20040006057 - Reiter, Lawrence Alan ; et al. | 2004-01-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 